Genix Receives Approval to Extend Warrants from the TSX Venture Exchange

Jul 28th, 2022 8:45 EST

Vancouver, British Columbia--(Newsfile Corp. - July 28, 2022) - Genix Pharmaceuticals Corporation (TSXV: GENX) (OTCQB: GENPF) ("GENIX" or the "Company") announces that the Company has received approval from the TSX Venture Exchange (the "Exchange") to extend 3,354,945 previously issued and outstanding warrants (the "Warrants") by eighteen (18) months (see July 20, 2022 press release).

In addition, Genix would like to provide a correction to the expiry date on 1,218,333 warrants as published July 20, 2022. The warrants that are set to expire August 13, 2022 and will be extended 18 months to February 13, 2024 not February 13, 2023 as was written in the press release.

About GenixGenix Pharmaceuticals Corporation is a novel and generic ophthalmic drugs company. The Company is focused on the research, development, manufacture, licensing and sales of novel and innovative healthcare products. In particular, these products include evidence-based, proprietary over-the-counter ("OTC") nutraceuticals, and other single molecule generic drugs that have been shown to deliver consistent and verifiable results in various therapeutic areas.

The Company will market and sell its portfolio of novel and generic ophthalmic drugs in Canada and globally and its nutraceutical products in North America and other select countries. Genix continues to conduct its scientific R&D of new, innovative products to support the health needs of mainstream consumers.

On Behalf of the Board of Directors,

Mr. Mahmoud Aziz, President, DirectorGenix Pharmaceuticals

For more information regarding Genix Pharmaceuticals Corporation, please contact:

Kevin Bottomley, DirectorTel: +1.604.609.6199[email protected]

Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

Statements included in this announcement, including statements concerning our plans, intentions and expectations, which are not historical in nature are intended to be, and are hereby identified as, "forward‐looking statements". Forward‐looking statements may be identified by words including "anticipates", "believes", "intends", "estimates", "expects" and similar expressions. The Company cautions readers that forward‐looking statements, including without limitation those relating to the Company's future operations and business prospects, are subject to certain risks and uncertainties that could cause actual results to differ materially from those indicated in the forward‐looking statements.

To view the source version of this press release, please visit


You must be logged in to post a comment.

Related Recent Publications

You must be logged in to post a comment.

Email newsletter

Receive the latest stock news and signals